CHEN, NAN – Trademark Portfolio
Entity Type: 01
CHEN, NAN owns a portfolio of 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CUNUWO, JMQJMQ, LBMLBM, XHISHU, and ZVLZVL. Of these, 14 are registered and 1 is pending. The portfolio spans 6 Nice Classification classes, led by Class 24 (Fabrics) and Class 5 (Pharmaceuticals). Headquartered in SHENZHEN CITY,GUANGDONG PROVINCE.
NO.10,GAOXIN SOUTH FOURTH ROAD,NANSHAN
DISTRICT,
SHENZHEN CITY,GUANGDONG PROVINCE , CN
Showing of trademarks Trademarks
Trademark Classifications
CHEN, NAN's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Precious metals and their alloys; jewellery, precious stones; horological instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does CHEN, NAN have?
CHEN, NAN has 16 U.S. trademarks filed with the USPTO. Of these, 14 registered, 1 pending, 1 abandoned.
What trademark classes does CHEN, NAN file in?
CHEN, NAN files trademarks across 6 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 21 (Housewares), Class 14 (Jewelry). Class 24 covers textiles and textile goods; bed covers; table covers.
What are CHEN, NAN's most well-known trademarks?
CHEN, NAN's registered trademark portfolio includes well-known marks such as CUNUWO, JMQJMQ, LBMLBM, XHISHU, and ZVLZVL. These are among 14 currently registered trademarks in the portfolio.
What is CHEN, NAN's trademark registration success rate?
CHEN, NAN has a 93% trademark registration rate, with 14 out of 15 resolved applications resulting in successful registration. Currently, 1 application is pending review.